EP Patent

EP2061761A1 — Phenethylamide derivatives with kinase inhibitory activity

Assigned to Millennium Pharmaceuticals Inc · Expires 2009-05-27 · 17y expired

What this patent protects

The present invention provides novel phenethylamide compounds of formula (I) useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of variou…

USPTO Abstract

The present invention provides novel phenethylamide compounds of formula (I) useful as inhibitors of protein kinases. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.

Drugs covered by this patent

Patent Metadata

Patent number
EP2061761A1
Jurisdiction
EP
Classification
—
Expires
2009-05-27
Drug substance claim
No
Drug product claim
No
Assignee
Millennium Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.